Simpson Thacher recently represented the underwriters, led by Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Capital Inc., Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC, in connection with a registered offering of $4.5 billion in notes by Pfizer Inc. The notes were issued in five series with maturities ranging from three to thirty years, with proceeds used for general corporate purposes, including the repayment of existing debt.
Pfizer is a research-based, global biopharmaceutical company. Pfizer’s global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products.
The Simpson Thacher team included Joe Kaufman, Tadashi Okamoto, Shelly Lin and Charlie Mathes (Capital Markets); Jon Cantor and Vanessa Grieve (Tax); Jamin Koslowe and David Mollo-Christensen (Executive Compensation and Employee Benefits); Adeeb Fadil and Noreen Lavan (Environmental); and Andrew Pagliughi and Jennie Getsin (FINRA and Blue Sky).